Delivery Order SPE2DB24D8001-SPE2DB25FKZCU
Award Date
1/29/25
Potential Completion Date
1/30/25
Potential Value
$6.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,902.10, was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business. The award has an ultimate completion date of January 28, 2025 and was issued as a delivery order under a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. The IDC, identified as SPE2DB24D8001, is part of the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products including Dupixent 300 mg/2 ml pens. The contract has a ceiling value of $11,049.12 and an ultimate completion date of May 22, 2024. It is a firm fixed-price contract awarded without a set-aside designation, reflecting Dakota Drug, Inc.'s established position as a reliable...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Dupixent 300 mg/2 ml syringes to support military medical operations. The contract has a ceiling value of $5,495.39 and a performance period extending through January 21, 2025. Dakota Drug, Inc. also holds a larger indefinite delivery contract (IDC) with the DLA, valued at $999,999,999.00, which...
The Defense Logistics Agency (DLA) awarded a $5,532.37 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 under the DLA Troop Support Medical's ECAT Generation V Program, which enables Dakota Drug, Inc. to deliver a comprehensive range of pharmaceutical and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,194.83 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Dupixent 300 mg/2 ml pens. This contract falls under Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures medical equipment, accessories, consumables, and simulation equipment. The contract has an ultimate...
This is a delivery order under a Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $1,867.25 and a period of performance through December 16, 2024. It is for the delivery of Dupixent 300 mg/2 mL syringes, a pharmaceutical product used for medical treatment. This award is not set aside and is part of the DLA Troop Support Medical's ECAT Generation V Program, a...
This is a delivery order award issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of Dupixent 300 mg/2 ml pens. The award, valued at $2,736.48, has a firm fixed price and an ultimate completion date of January 23, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products, medical...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a pharmaceutical product used in medical treatment. The contract has a ceiling value of $2,758.88 and a completion date of February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract, with a ceiling value of $6,318.05, has a firm fixed price pricing type and a performance period extending through January 21, 2025. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC)...
This federal contract award, valued at $3,826.50, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) valued at $999,999,999.00. This delivery order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a completion date of December 13, 2024. The contract does not have...